how often do you microdose glp 1 Low-Dose and GLP-1 for Longevity – Andy Cohen Lost 25 Lbs

And they didn't gain weight

Clinical Data from Competitor Agents: Strengths and Limitations of CT-388 in Light of Competitor Data: Strengths: - CT-388 demonstrates a positive safety and tolerability profile with manageable GI-related side effects that are consistent with the incretin class.- CT-388 has shown statistically significant weight loss across cohorts in its Phase 1/2 trial, with the highest dose cohort (Cohort 8) averaging an 8.4% weight loss at four weeks.- The prolonged half-life of CT-388 suggests the potential for once-weekly dosing, which could bolster adherence compared to therapies requiring more frequent administration.- Weight loss with CT-388 is accompanied by improvements in metabolic parameters such as waist circumference and HOMA-IR, indicating a potential benefit for patients with obesity and associated comorbidities

In Phase 3 studies, GLP-1 agonists demonstrated significant weight loss

The gel base give an immediate improvement and then breaks down over a period of weeks

Compounded topical peptides for skin and hair Compounded topical peptides differ from over-the-counter peptide serums in two ways: prescription concentrations (1 to 3 percent GHK-Cu versus 0.05 to 0.1 percent OTC) and provider-customized formulas